Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1

Tumori. 2007 Mar-Apr;93(2):230-1. doi: 10.1177/030089160709300226.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Adolescent
  • Benzamides
  • Drug Resistance, Neoplasm
  • Female
  • Genes, Wilms Tumor / physiology*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate